Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Peginterferon-α-2b/ribavirin

Myasthenia gravis (first report with peginterferon-α-2b): case report

    • 6 Accesses

    This is a preview of subscription content, log in to check access.

    REFERENCE

    1. 1.

      Bektas M, Bektas H, Goren D, Altan M, Cetinkaya H.Development of myasthenia gravis due to treatment of chronic hepatitis C with a combination of interferon-alpha and ribavirin. Digestion 75: 208-209, No. 4, 2007 - Turkey

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Peginterferon-α-2b/ribavirin. React. Wkly. 1186, 31 (2008). https://doi.org/10.2165/00128415-200811860-00099

    Download citation

    Keywords

    • Public Health
    • Hepatitis
    • Interferon
    • Patient Outcome
    • Congenital Anomaly